How Can I Tell if Mounjaro Is Working? (October 2026)

01 · The short answer

What to look for, and when

The clearest early sign that Mounjaro is working is that you feel fuller sooner and less hungry between meals. Tirzepatide activates two natural gut-hormone receptors, GIP and GLP-1, which help regulate appetite and slow how quickly the stomach empties.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

Weight change comes later and more unevenly. Weight loss on Mounjaro is gradual by design, and the first weeks on 2.5mg are an adjustment phase where losses are usually modest.¹ Most measurable progress builds from 5mg onward, month by month.

Some people notice appetite change and early loss straight away, while others feel little until a higher dose. Both are normal.¹

02 · Your next step

Is it working for you? Two decisions to make

The first decision is whether you are judging too early. If you are still on the starting dose, or have only just stepped up, the dose you respond to may still be ahead of you. Keep a simple weekly record of weight, waist and appetite so you can see the trend rather than the noise. The free GLPTrackr companion app is designed for tracking a GLP-1 journey on iOS and Android.

The second decision is whether to raise it with your prescriber. Treatment is reviewed by a prescriber, and if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Never change your dose or add unlicensed products on your own. Our ongoing monthly reviews are there for exactly this conversation.

If you are not yet a patient and are weighing up treatment, you can read about the Mounjaro pen and its consultation, or browse our wider weight loss clinic information. Treatment is supplied only after a free online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

If your concern is the pen rather than the medicine, check our guide to a Mounjaro pen not working, because a faulty or mishandled pen can look like a medicine that is not working.

03 · Appetite and food noise

Appetite, fullness and food noise

Changes in appetite are the most common early sign that Mounjaro is doing its job. Tirzepatide activates the GIP and GLP-1 receptors, which help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹ That is why most people feel fuller sooner and less hungry between meals.

What does that look like day to day? You may sit down to a meal and feel satisfied well before your plate is empty. You may notice that the gap between meals no longer feels like a battle, or that you simply forget a snack you would normally have reached for. Many people describe a quieter mind around food, with fewer thoughts about what to eat next. That is a useful self-check, but it is a personal impression rather than a measurement.

Slower stomach emptying also changes how food feels. Large or rich meals may sit heavily, and you may find you naturally choose smaller portions. Mild nausea, altered appetite and tiredness in the days after each injection are the commonest early effects and usually settle.¹ It is worth knowing that feeling a side effect is not proof the medicine is working, and feeling none is not proof it is failing.

A practical way to track appetite is a simple weekly rating. Note how hungry you felt before meals, how quickly you felt full and how often you thought about food. Over a few weeks a pattern appears. If your appetite is the same as before you started, and you are still on the starting dose, that is not unusual, because the starting dose is about letting your body adjust.

Appetite changes can also fade or shift as you move between doses. Do not read a single hungrier day as failure. Look at the pattern across several weeks, and think about sleep, stress and illness, which all affect hunger independently of any medicine.

Remember that appetite suppression is a tool, not the whole plan. Mounjaro is used alongside a reduced-calorie diet and increased physical activity. With less hunger, it is easier to choose protein-rich, filling food and keep portions sensible, and that is where the medicine and your habits combine. If you feel so full that you cannot eat enough, tell your prescriber rather than pushing through.

If your appetite has not changed at all after several weeks on a dose, raise it at your next review. Your prescriber can check that you are injecting correctly, look at your pace of titration and decide whether a step-up is appropriate within the licence.

04 · The early weeks

The early weeks on 2.5mg

The starting weeks are about adjustment, and experiences differ widely. Everyone starts Mounjaro on 2.5mg once a week, and this starting dose is about letting your body adjust, not about weight loss itself.¹ That is the honest answer to anyone asking whether they can lose weight on the lowest strength: some people do, and many see very little.

Some people notice appetite change and early loss in the very first week, while others feel little until a higher dose. Both are normal.¹ Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. A big drop in the opening days is therefore not a promise of what follows, and a flat start is not a verdict.

After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹ Many people settle at a maintenance dose of 5mg, 10mg or 15mg, and higher is not automatically better. Your prescriber will guide the right pace.

What should you watch during this phase? Focus on the process rather than the outcome. Are you injecting on the same day each week? Are you eating regular, protein-rich meals? Are side effects manageable? These are things you control. Early nausea, altered appetite and tiredness are common and usually settle, and if they do not, your prescriber can adjust the plan within the licence.

It also helps to set expectations in terms of months. Our related guide on telling whether a pen has frozen may matter here too, because a frozen pen should never be used and can mimic a lack of effect. Keep pens in the fridge and never use one that has been frozen.

The aim of the first weeks is to arrive at a dose that you tolerate and that begins to change your appetite. Treat the period as a foundation. If you step up and feel a clearer change in fullness, that is often a sign that the dose is starting to bite. If you feel nothing at all, note it down and discuss it, rather than assuming the medicine cannot work for you.

05 · Scales, trend and pace

What the scales should show

The scales should show a gradual downward trend over weeks and months, not a straight line. Weight loss on Mounjaro is gradual by design, and trials measured results at 72 weeks. Think in months, not days, and judge progress by trend, not individual weigh-ins.¹

Three months in, most people are still on the lower rungs of the dose ladder. A sensible 3-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.¹ Slower early progress does not predict failure, because the dose you respond to may still be ahead of you.

Many people ask whether a steady weekly loss is normal. Weekly figures bounce around with water, salt, hormones, bowel habits and the time of day you weigh. A fairer test is whether the direction over several weeks is downward.

To get a clean trend, weigh yourself at the same time of day, on the same scales, under similar conditions, and no more often than suits you. Some people prefer one weekly weigh-in; others use a monthly average. Plot the points rather than reacting to each one. If a week shows a small rise, look at the surrounding weeks before drawing conclusions.

Compare your experience with the trial headline carefully. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary. They are measured at 72 weeks, not at a few weeks, so they are not a yardstick for the opening month.

If you are keen on a worked example, for someone starting at 100 kg, 20.9% is about 21 kg. That is the straight arithmetic of the trial average at the highest dose after 72 weeks, not a prediction for you, and not a pace.

Finally, remember the review point. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹

06 · Beyond the scales

Beyond the scales: clothes, waist and health markers

Clothes fit, waist size and health markers often show progress before or alongside the scales. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.¹ These are trial-average secondary outcomes, not promises.

That is why prescribers talk about weight management as health management rather than appearance. If your waistband is looser, a belt moves in a notch or a garment hangs differently, that tells you something real is changing, even if your weight looks stubborn. Body composition and water balance shift in ways that a single number cannot capture.

A simple routine helps. Take a waist measurement at the same point, at the same time of day, at regular intervals, and keep a photo or two for your own reference. Note how stairs, walking and everyday tasks feel, since energy and ease of movement are meaningful outcomes in their own right.

Health markers are different. You cannot feel your cholesterol or blood sugar change, so these need tests arranged through the right clinician. If you have a condition such as high blood pressure or type 2 diabetes, tell the clinicians managing it that you are taking Mounjaro, because they may want to review your other treatments. If you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar, and that is a conversation for your prescriber, not a reason to change anything yourself.

It is also useful to separate progress from outcomes you cannot judge at home. A better mood about food, a steadier relationship with eating and more confidence in activity are legitimate signs of progress even without a big change on the scales. Equally, rapid change that leaves you weak, dizzy or unable to eat is not a sign of success, and should be discussed with your prescriber.

Treat the scales as one instrument among several. When the scales, the tape measure, the mirror and the way you feel point the same direction, you can be confident of progress. When they disagree, give it time, keep recording, and use your review to talk it through.

07 · Injecting properly

Checking you are injecting properly

If you doubt whether Mounjaro is working, first confirm you are injecting it as licensed. Mounjaro is injected under the skin (subcutaneously) once a week, on the same day each week, at any time of day, with or without food.¹ Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose.

The KwikPen is set by turning the dose knob until the dose indicator shows the correct dose in the window. Follow the pen's instructions for completing the injection, as set out in the patient information leaflet.¹³

If you are unsure whether you received a full dose, do not inject again to compensate. Contact the pharmacy or your prescriber, who can advise on your particular situation. Our guides on telling if a pen is empty and what to do if a pen jams walk through those problems.

Timing matters too. There is no best time of day, because Mounjaro works the same morning or evening, with or without food. What matters is the same day each week.¹ Many people choose a weekend morning so early side effects fall on days off.

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day, and never take two doses within 3 days of each other.¹ You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.

Storage affects whether a pen is fit to use. Keep pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Keep the cap on to protect it from light, and never use a pen that has been frozen.¹

08 · Plateaus and stalls

What to do when progress stalls

A stall of a few weeks does not mean Mounjaro has stopped working. Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹

Within the licence, the responses are practical. Review your food intake honestly, because portions drift back up without anyone noticing. Protect protein and activity. Check the basics, including sleep and alcohol. Then discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹ A plateau is not a reason to double doses or add unlicensed products.

Here is a way to work through it. Start with a short food diary over a typical week, including drinks, snacks and weekend eating. Many people are surprised by liquid calories and grazing. Next, look at protein, since eating enough protein helps you feel full and protect muscle while you lose weight. Then consider movement: it does not need to be dramatic, but regular walking and some strength work make a difference alongside the medicine.

Sleep and stress matter more than most people expect. Poor sleep tends to raise appetite, and stress can drive eating that the medicine alone does not overcome. Alcohol adds calories and can loosen your food choices, so it is on the list of basics worth checking when progress stalls. There is no direct interaction between Mounjaro and alcohol, but drinking on a reduced appetite and emptier stomach can hit harder than usual. If you also take insulin or a sulfonylurea, alcohol increases the risk of low blood sugar.

If you have been on one dose for a while with little change in appetite or weight, your prescriber may consider the next step. Doses step up by 2.5mg at a minimum of 4-week intervals, depending on how you respond and tolerate it, and many people settle at 5mg, 10mg or 15mg.¹ Higher is not automatically better, and some people do well at lower strengths.

Tell your prescriber about any new symptom rather than guessing, and report suspected side effects through the MHRA Yellow Card scheme.¹⁹ If you suspect a problem with the pen itself, our guide to a pen not working covers the practical checks.

Plateaus are frustrating but usually temporary. The best response is steady, honest review rather than drastic changes. Record, adjust within the licence, and give each change enough time to show.

09 · Trial evidence in context

What the trial evidence means for you

Trial results show what groups of people achieved on average, not what you will personally see. In SURMOUNT-1, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

The trial also reports how many people reached particular thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Those figures are measured at the end of a long treatment period, so they should not be used to judge the opening weeks.

How should you use this? Mainly as context. If you are in the early weeks and the scales have barely moved, the trial pattern says average losses built month by month, with the full averages measured at 72 weeks, not 12.¹ If you are further along and still seeing little, the trial figures show that some people respond more than others, which is exactly why individual review matters.

It is equally important not to over-read the headline. A trial average does not predict your own result. Your starting weight, health conditions, diet, activity, sleep and dose all play a part, and the prescriber reviewing your treatment is better placed than any average to judge your response.

You may also see results for other medicines in the news or on social media. Different trials use different designs, so numbers from separate studies should never be set side by side as if they were a head-to-head contest. When in doubt, ask your prescriber what a figure means for you.

The takeaway is a balanced one. The evidence for tirzepatide is strong, but it is an average built over many months, delivered together with diet and activity changes.

10 · Reviews and next steps

Reviews, support and getting more from treatment

Regular review is how you turn vague impressions into decisions. Treatment response is reviewed by your prescriber, and the formal check is clear: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Notice the wording: the highest tolerated dose. Being on the starting dose for a few weeks is not the same situation.

With us, aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Repeat orders re-check suitability, and there is no auto-shipping. Orders come through a free online consultation reviewed by a GPhC-registered prescriber, dispensed by our registered pharmacy (GPhC 9012878), and delivered free next day in temperature-controlled packaging. Needles, a sharps bin and injection guidance are included with every order.

Mounjaro is also available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. You can read more in the NHS tirzepatide guide.⁵

What should you bring to a review? A short log of weight and waist, a note on appetite and fullness, any side effects, how you are eating and moving, and anything that has changed in your health or other medicines. The more specific you are, the more useful the discussion. If you find yourself hungrier than before or unable to eat, tell your prescriber. If you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away.

Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. This page is information, not a substitute for medical advice.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹